Browsing by Author "Das, Agnidipta"
Now showing items 1-3 of 3
-
Effectiveness of Selective Estrogen Receptor Modulators in Breast Cancer Therapy: An Update
Das, Agnidipta; Lavanya, Kanamarlapudi Joshna; Nandini; Kaur, Kamalpreet; Jaitak, Vikas (Bentham Science Publishers, 2022-10-06)Background: Breast cancer is considered to be 2nd most common cancer sub-type investigated worldwide. It is mainly prevalent in postmenopausal women. Estrogen Receptor (ER) is a primary transcription factor for the survival ... -
Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer
Mandal, Sudip Kumar; Das, Agnidipta; Bose, Anindya; Dwibedi, Vagish; Ganguly, Paramita; Sarkar, Sipra; Prakash, Ranjana; Dey, Biplab Kumar; Mandal, Sanjeet; Rath, Santosh Kumar (Bentham Science Publishers, 2023-01-02)Triple-negative breast cancer (TNBC) holds just about 15% of all breast tumours and sub-types of breast cancer with distinct characteristics of negative expressions for the progesterone recep-tor, estrogen receptor, and ... -
Identification of 1,3,4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach
Das, Agnidipta; Sarangi, Manaswini; Jangid, Kailash; Kumar, Vijay; Kumar, Amit; Singh, Praval Pratap; Kaur, Kamalpreet; Kumar, Vinod; Chakraborty, Sudip; Jaitak, Vikas (Taylor and Francis Ltd., 2023-09-11)Cancer is one of the most prominent causes of death worldwide and tubulin is a crucial protein of cytoskeleton that maintains essential cellular functions including cell division as well as cell signalling, that makes an ...